NASDAQ · Financial Statements

IBEX Limited - Common Share (IBEX) Financial Statements

$47.23 NASDAQ: IBEX Market Cap $627.15M

IBEX Limited - Common Share most recently reported annual revenue of $644.0M, net profit of $46.0M. Revenue grew at an average annual rate of 7.8% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

IBEX Limited - Common Share: Revenue rose from $334.0M in 2017 to $644.0M in 2026, a change of +92.8% over 9 years; net profit was positive in 7 of 10 reported years; operating margin moved from -0.7% to 8.5%, a shift of +9.2 percentage points; the most recent year shows net profit of $46.0M.

Income Statement — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Revenue$334.0M$342.0M$368.0M$405.0M$443.0M$493.0M$523.0M$509.0M$558.0M$644.0M
Operating Expenses$336.0M$360.0M$362.0M$386.0M$426.0M$472.0M$483.0M$469.0M$512.0M$589.0M
Operating Profit$-2.0M$-18.0M$7.0M$20.0M$17.0M$21.0M$40.0M$39.0M$47.0M$55.0M
Operating Margin-0.7%-5.2%1.9%4.8%3.8%4.2%7.7%7.8%8.3%8.5%
Other Income$-6.0M$-3.0M$-8.0M$-9.0M$-2.0M$-1.0M$0$2.0M$-1.0M$-1.0M
Interest$5.0M$2.0M$7.0M$9.0M$9.0M$1.0M$1.0M$1.0M$2.0M$1.0M
Depreciation$14.0M$12.0M$21.0M$24.0M$14.0M$18.0M$19.0M$19.0M$17.0M$20.0M
Profit Before Tax$-9.0M$-21.0M$-1.0M$10.0M$15.0M$19.0M$40.0M$41.0M$46.0M$54.0M
Tax$-3.4M$520,000$-399.9M$22.9M$13.6M$-10.7M$21.7M$17.9M$19.7M$-14.7M
Net Profit$-9.0M$-16.0M$-5.0M$8.0M$13.0M$21.0M$32.0M$34.0M$37.0M$46.0M
EPS$-0.51$-0.90$-0.26$0.44$0.15$1.15$1.67$1.84$2.36$3.13
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$125.0M$133.0M$127.0M$125.0M$130.0M$141.0M$141.0M$147.0M$151.0M$164.0M$164.0M$164.0M
Operating Expenses$116.0M$126.0M$116.0M$112.0M$121.0M$129.0M$127.0M$135.0M$137.0M$149.0M$148.0M$154.0M
Operating Profit$8.0M$7.0M$11.0M$13.0M$9.0M$12.0M$13.0M$12.0M$14.0M$15.0M$16.0M$10.0M
Operating Margin6.7%5.2%8.9%10.3%7.0%8.5%9.5%8.3%9.1%9.3%9.8%6.0%
Interest$0$0$0$0$0$1.0M$0$0$0$0$0$0
Profit Before Tax$9.0M$7.0M$12.0M$13.0M$10.0M$12.0M$13.0M$12.0M$14.0M$15.0M$16.0M$10.0M
Tax$15.8M$17.3M$11.0M$25.6M$20.8M$20.2M$19.2M$19.0M$10.9M$19.1M$16.6M$-10.0M
Net Profit$7.0M$6.0M$10.0M$10.0M$8.0M$9.0M$10.0M$10.0M$12.0M$12.0M$13.0M$9.0M
EPS$0.39$0.33$0.57$0.56$0.43$0.57$0.73$0.66$0.82$0.83$0.89$0.59

Over the 10 years reported for IBEX Limited - Common Share, borrowings increased from $58.0M in 2017 to $62.0M in 2026, cash stood at $33.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 2.09 times.

Balance Sheet — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Total Assets$152.0M$157.0M$188.0M$195.0M$274.0M$294.0M$293.0M$294.0M$273.0M$309.0M
Current Assets$89.0M$82.0M$82.0M$86.0M$141.0M$142.0M$159.0M$180.0M$146.0M$180.0M
Cash$21.0M$14.0M$9.0M$22.0M$58.0M$49.0M$57.0M$63.0M$15.0M$33.0M
Inventory$1.0M$0$0$0$0$0$0$0$0$0
Receivables$64.0M$60.0M$64.0M$58.0M$73.0M$75.0M$92.0M$108.0M$119.0M$130.0M
Fixed Assets$23.0M$19.0M$82.0M$85.0M$107.0M$125.0M$112.0M$89.0M$95.0M$96.0M
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$0$0$0$3.0M$0$0$0$0$0$0
Other Assets$12.0M$12.0M$12.0M$12.0M$12.0M$12.0M$12.0M$12.0M$12.0M$12.0M
Total Liabilities$123.0M$129.0M$180.0M$179.0M$194.0M$181.0M$143.0M$128.0M$139.0M$139.0M
Current Liabilities$100.0M$116.0M$111.0M$106.0M$106.0M$98.0M$73.0M$71.0M$80.0M$86.0M
Borrowings$58.0M$63.0M$118.0M$106.0M$113.0M$106.0M$79.0M$67.0M$70.0M$62.0M
Other Liabilities$66.0M$66.0M$61.0M$73.0M$81.0M$75.0M$64.0M$61.0M$69.0M$76.0M
Equity$0$0$0$0$0$0$0$0$0$0
Reserves$29.0M$28.0M$9.0M$16.0M$81.0M$113.0M$150.0M$166.0M$134.0M$170.0M

For IBEX Limited - Common Share, operating cash flow was positive in 9 of 10 reported years; free cash flow in the latest year was $31.0M; free cash flow was positive in 6 of 10 years; financing activities used $17.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Operating Cash Flow$7.0M$-6.0M$2.0M$52.0M$16.0M$40.0M$42.0M$36.0M$46.0M$59.0M
Investing Cash Flow$-20.0M$-11.0M$-15.0M$-9.0M$-42.0M$-52.0M$-38.0M$-18.0M$-37.0M$-56.0M
Financing Cash Flow$0$0$-6.0M$-15.0M$-1.0M$-3.0M$2.0M$-21.0M$-74.0M$-17.0M
Net Cash Flow$12.0M$-8.0M$-5.0M$13.0M$36.0M$-9.0M$9.0M$5.0M$-47.0M$17.0M
Free Cash Flow$-3.0M$-12.0M$-4.0M$47.0M$-5.0M$14.0M$23.0M$27.0M$27.0M$31.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.37
EV / EBITDA7.95
FCF Yield5.35%
Quick Ratio2.10
Interest Coverage111.72
Return 1Y4.14%
Return 3Y62.19%
Return 5Y64.90%

IBEX Limited - Common Share (IBEX) financials — frequently asked questions

What is IBEX Limited - Common Share's annual revenue?

IBEX Limited - Common Share (IBEX) reported annual revenue of $644.0M in its most recent fiscal year.

What is IBEX Limited - Common Share's net profit?

IBEX Limited - Common Share (IBEX) reported net profit of $46.0M in its most recent fiscal year.

What is IBEX EV/EBITDA?

IBEX Limited - Common Share's enterprise value to EBITDA (EV/EBITDA) ratio is 7.95.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Technology StocksLow P/E Technology StocksHigh Net Margin Technology StocksDividend Technology StocksLow Debt Technology StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
IBEX Overview IBEX Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.